Literature DB >> 3279993

Haematogenous dissemination of cells from human renal adenocarcinomas.

D Glaves1, R P Huben, L Weiss.   

Abstract

Estimates were made of the rates at which cancer cells were released directly into the renal vein in patients undergoing radical nephrectomy for primary renal cancer. Cancer cells were counted in blood samples taken from the renal vein using a density gradient centrifugation procedure, and identified using immunocytochemical techniques, on the basis of their cytoskeletal intermediate filament proteins. Cancer cells were released as single cells and multicell emboli in 8/10 patients, in numbers varying widely between 14-7509 emboli ml-1 of blood. Despite a calculated median input into the metastatic process of 3.7 x 10(7) cancer cells per day for at least 180 days, only 3/10 patients had extraperitoneal metastases prior to surgery and only 1 of the remaining disease-free patients subsequently developed distant metastases over a maximum 35 month period. These results are discussed in terms of primary tumour kinetics and metastatic inefficiency.

Entities:  

Mesh:

Year:  1988        PMID: 3279993      PMCID: PMC2246676          DOI: 10.1038/bjc.1988.4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  PROSPICE--TUMOR CELLS IN CIRCULATING BLOOD.

Authors:  E M NADEL
Journal:  Acta Cytol       Date:  1965 Mar-Apr       Impact factor: 2.319

Review 2.  Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations.

Authors:  D Cooper; A Schermer; T T Sun
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

3.  Conservation of epithelial cell phenotypes during hematogenous metastasis from mammary carcinomas.

Authors:  D Glaves; D A Ketch; B B Asch
Journal:  J Natl Cancer Inst       Date:  1986-05       Impact factor: 13.506

4.  The hemodynamic destruction of circulating cancer cells.

Authors:  L Weiss
Journal:  Biorheology       Date:  1987       Impact factor: 1.875

5.  Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency.

Authors:  L Weiss
Journal:  Int J Cancer       Date:  1980-03-15       Impact factor: 7.396

6.  Selective therapy of metastasis. I. Quantitation of tumorigenic circulating and covert cancer cells disseminated from metastatic and nonmetastatic tumors.

Authors:  D Glaves; E Mayhew
Journal:  Cancer Drug Deliv       Date:  1984

7.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.

Authors:  D Tarin; J E Price; M G Kettlewell; R G Souter; A C Vass; B Crossley
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

8.  Metastasis: reticuloendothelial system and organ retention of disseminated malignant cells.

Authors:  D Glaves
Journal:  Int J Cancer       Date:  1980-07-15       Impact factor: 7.396

9.  A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis.

Authors:  L Weiss; D S Dimitrov
Journal:  Cell Biophys       Date:  1984-03

10.  Quantitation of tumorigenic disseminating and arrested cancer cells.

Authors:  E Mayhew; D Glaves
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

View more
  33 in total

1.  Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer.

Authors:  Moritz Koch; Dalibor Antolovic; Peter Kienle; Johanna Horstmann; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Int J Colorectal Dis       Date:  2006-06-07       Impact factor: 2.571

Review 2.  Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency.

Authors:  L Weiss
Journal:  Cell Biophys       Date:  1991-04

Review 3.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

4.  Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer.

Authors:  Peilin Huang; Jingmei Wang; Ying Guo; Wei Xie
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-18       Impact factor: 4.553

Review 5.  Molecular analysis of circulating tumour cells-biology and biomarkers.

Authors:  Matthew G Krebs; Robert L Metcalf; Louise Carter; Ged Brady; Fiona H Blackhall; Caroline Dive
Journal:  Nat Rev Clin Oncol       Date:  2014-01-21       Impact factor: 66.675

Review 6.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

7.  Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma.

Authors:  Jan Friederichs; Ralf Gertler; Robert Rosenberg; Jörg Nahrig; Katrin Führer; Bernhard Holzmann; Hans-Joachim Dittler; Michael Dahm; Stefan Thorban; Hjalmar Nekarda; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

8.  Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease.

Authors:  J E Hardingham; D Kotasek; R E Sage; M C Eaton; V H Pascoe; A Dobrovic
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

9.  In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells.

Authors:  Dmitry A Nedosekin; Vladislav V Verkhusha; Alexander V Melerzanov; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Chem Biol       Date:  2014-05-08

10.  Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer.

Authors:  M Koch; P Kienle; P Sauer; F Willeke; K Buhl; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz; J Weitz
Journal:  Surg Endosc       Date:  2004-01-23       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.